These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7395608)

  • 1. Ergot drugs in the treatment of endocrine disorders: introduction.
    Kleinberg DL; Frantz AG
    Adv Biochem Psychopharmacol; 1980; 23():143-6. PubMed ID: 7395608
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromocriptine therapy of hyperprolactinemic disorders.
    Friesen HG
    Adv Biochem Psychopharmacol; 1980; 23():147-54. PubMed ID: 7395609
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dopaminergic ergot combinations. A new therapeutic principle].
    von Werder K
    MMW Munch Med Wochenschr; 1983 Jun; 125(23):489-91. PubMed ID: 6410211
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hyperprolactinemias: a matter of controversy.
    Carmina E; Jannì A
    Acta Eur Fertil; 1983; 14(4):241-7. PubMed ID: 6673443
    [No Abstract]   [Full Text] [Related]  

  • 5. [New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma].
    Geyer G
    Wien Med Wochenschr; 1980 Aug; 130(15-16):501-9. PubMed ID: 6258331
    [No Abstract]   [Full Text] [Related]  

  • 6. High prolactin level.
    Piketty ML; Nataf F; Dilouya A; Roux FX
    J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperprolactinemia: current concepts of management including medical therapy with bromocriptine.
    Thorner MO; Evans WS; MacLeod RM; Nunley WC; Rogol AD; Morris JL; Besser GM
    Adv Biochem Psychopharmacol; 1980; 23():165-89. PubMed ID: 7395611
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperprolactinemia.
    Kemmann E; Jones JR
    Am Fam Physician; 1981 Mar; 23(3):119-24. PubMed ID: 7468401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disorders of prolactin secretion.
    Thorner MO
    J Clin Pathol Suppl (Assoc Clin Pathol); 1976; 7():36-41. PubMed ID: 1073164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of hyperprolactinemia].
    Schatz H
    Dtsch Med Wochenschr; 1985 Jun; 110(24):964-6. PubMed ID: 3996238
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern drug treatment of hyperprolactinemia].
    Rachev E; Spasov S
    Akush Ginekol (Sofiia); 1985; 24(6):81-4. PubMed ID: 3911788
    [No Abstract]   [Full Text] [Related]  

  • 13. Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumor size as predicting factors.
    Aubourg PR; Derome PJ; Peillon F; Jedynak CP; Visot A; Le Gentil P; Balagura S; Guiot G
    Surg Neurol; 1980 Aug; 14(2):141-3. PubMed ID: 7414500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parlodel in lactation mastitis].
    Dolzhikov AL; Kliachkin ML
    Sov Med; 1986; (8):115-6. PubMed ID: 3775505
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic and antidyskinetic properties of ergot dopamine agonists.
    Tamminga CA
    Adv Biochem Psychopharmacol; 1980; 23():397-403. PubMed ID: 7395624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics].
    Mercier C
    J Pharm Belg; 1982; 37(4):289-98. PubMed ID: 6754905
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolactin adenoma with ophthalmological manifestations. Treatment with bromocriptine].
    Saraux H; Offret H; Brasnu C; Charpentier G
    Bull Soc Ophtalmol Fr; 1980; 80(6-7):489-93. PubMed ID: 7408092
    [No Abstract]   [Full Text] [Related]  

  • 18. [Causes and treatment of prolactinemia].
    Jeske W
    Pol Tyg Lek; 1980 Feb; 35(7):247-9. PubMed ID: 6988822
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of prolactin by an ergot-alkaloid derivative].
    Wenner R; Varga L
    Gynakol Rundsch; 1973; 13():Suppl 1:64-5. PubMed ID: 4798936
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.